KAMAL, .., HEFNAWI, .., YOUNIS, .. (1970). LYNESTRENOL 1 mg.-mestranol 0.1 mg. a new low dose oral contraceptive. a clinical study. test, 3(1), 11-15. doi: 10.21608/mskas.1970.417012
.I KAMAL; .F HEFNAWI; .N YOUNIS. "LYNESTRENOL 1 mg.-mestranol 0.1 mg. a new low dose oral contraceptive. a clinical study". test, 3, 1, 1970, 11-15. doi: 10.21608/mskas.1970.417012
KAMAL, .., HEFNAWI, .., YOUNIS, .. (1970). 'LYNESTRENOL 1 mg.-mestranol 0.1 mg. a new low dose oral contraceptive. a clinical study', test, 3(1), pp. 11-15. doi: 10.21608/mskas.1970.417012
KAMAL, .., HEFNAWI, .., YOUNIS, .. LYNESTRENOL 1 mg.-mestranol 0.1 mg. a new low dose oral contraceptive. a clinical study. test, 1970; 3(1): 11-15. doi: 10.21608/mskas.1970.417012

LYNESTRENOL 1 mg.-mestranol 0.1 mg. a new low dose oral contraceptive. a clinical study

المجلة المصرية للسکان وتنظيم الأسرة
Volume 3, Issue 1, June 1970, Pages 11-15    PDF (3.82 M)
Document Type: المقالة الأصلية
DOI: 10.21608/mskas.1970.417012
Authors
.I KAMAL1; .F HEFNAWI* 2; .N YOUNIS* 1
1department of Obstetrics and Gynaecology. Al-Azher University .
2department of Obstetrics and Gynaecology. Al-Azher University .
Abstract
The development of new contraceptives is an indispensable adjunct to the solution of the world wide problems related to the explosive population growth. It is generally agreed that an optimum ratio should be present between the progestogen and the oestrogen part of any pill. Lowering too much the oestrogen will lead to ovulation escapes. Lowering of the progestogen part is supposed to lower the side effects and leads to a commercially cheap preparation. The present report presents our experience with a new preparation combining 1 mg. of Lynestrenol and. 0.1 mg. of Mestranol per tablet.
Keywords
contraceptive
Statistics
Article View: 14
PDF Download: 62